Security key
31572Q808
KYNTRA BIO, INC. - Common Stock, $0.01 par value (FGEN)
CUSIP: 31572Q808
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Common Stock, $0.01 par value
- Total 13F shares
- 61,231,274
- Total 13F value
- $143,890,300
- Share change
- -8,689,063
- Put/Call ratio
- 15%
- SEC-reported price per share
- $2.35
- Number of holders
- 106
- Value change
- -$18,865,510
- Number of buys
- 48
- Number of sells
- 54
- Shares outstanding
- 4,048,583
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
106
Top holders
10
FGEN full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
KYNTRA BIO, INC. SEC filings
KYNTRA BIO, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31572Q808
Recent filing periods:
Ownership snapshot
Top reported holders of FGEN - KYNTRA BIO, INC. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
PRIMECAP MANAGEMENT CO/CA/
Disclosed value leader
PRIMECAP MANAGEMENT CO/CA/
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
Lead comparable stake: 357%
Showing 1-6 of 15 holder rows.
Quick read
PRIMECAP MANAGEMENT CO/CA/ leads the comparable SEC ownership view at 357%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens PRIMECAP MANAGEMENT CO/CA/'s linked filing trail.
Comparable ownership
Top 5
PRIMECAP MANAGEMENT CO/CA/
357%
ARMISTICE CAPITAL, LLC
241%
BlackRock Finance, Inc.
178%
VANGUARD GROUP INC
174%
JACOBS LEVY EQUITY MANAGEMENT, INC
61%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13F
Company
|
357%
|
$12,826,470
14,471,928 shares
|
— | 31 Dec 2023 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
241%
|
$8,653,833
9,764,000 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
178%
|
$6,386,058
7,205,300 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
174%
|
$6,243,229
7,044,149 shares
|
— | 31 Dec 2023 |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
Company
|
61%
|
$2,206,449
2,489,506 shares
|
— | 31 Dec 2023 |
| ACADIAN ASSET MANAGEMENT LLC |
13F
Company
|
61%
|
$2,187,000
2,468,928 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
106
Shares
61,231,274
Rows available
106
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
106
Q1 2024 holders
106
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend